Effects of Selegiline on negative symptoms in schizophrenia: A double-blind, placebo-controlled, study

被引：0
|
作者：
Abdollahian, E. [1 ]
Hodjat, K. [1 ]
机构：
[1] Mashhad Univ Med Sci, Mashhad, Iran
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study
    Amiri, Afshar
    Noorbala, Ahmad-Ali
    Neiatisafa, Ali-Akbar
    Ghoreishi, Abolfazl
    Derakhshan, Mohammad-Kamran
    Khodaie-Ardakani, Mohammad-Reza
    Hajiazim, Mohammad
    Raznahan, Maedeh
    Akhondzadeh, Shahin
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2008, 23 (02) : 79 - 86
  • [2] A double-blind placebo-controlled trial of modafinil for negative symptoms in schizophrenia
    Pierre, JM
    Peloian, JH
    Wirshing, DA
    Wirshing, WC
    Marder, SR
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 93S - 93S
  • [3] Adjunctive armodafinil for negative symptoms in adults with schizophrenia: A double-blind, placebo-controlled study
    Kane, John M.
    Yang, Ronghua
    Youakim, James M.
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 135 (1-3) : 116 - 122
  • [4] ADJUNCTIVE ARMODAFINIL FOR NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Kane, John M.
    Youakim, J. M.
    Yang, R.
    Tiller, J.
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 307 - 308
  • [5] Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia
    Bodkin, JA
    Siris, SG
    Bermanzohn, PC
    Hennen, J
    Cole, JO
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (02): : 388 - 390
  • [6] A randomized, double-blind, placebo-controlled trial on modafinil for negative symptoms in schizophrenia
    Pierre, Joseph M.
    Peloian, John H.
    Wirshing, Donna A.
    Wirshing, William C.
    Marder, Stephen R.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (05) : 705 - 710
  • [7] Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics:: a double-blind placebo-controlled study
    Jockers-Scherübl, MC
    Bauer, A
    Godemann, F
    Reischies, FM
    Selig, F
    Schlattmann, R
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (01) : 27 - 31
  • [8] Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics:: A double-blind placebo-controlled study
    Jockers-Scherübl, MC
    Bauer, A
    Godemann, F
    Reischies, F
    Selig, F
    Schlattmann, P
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 146 - 146
  • [9] Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics:: A double-blind placebo-controlled study
    Jockers-Scherübl, MC
    Bauer, A
    Godemann, F
    Reischies, FM
    Selig, F
    Schlattmann, P
    [J]. PHARMACOPSYCHIATRY, 2003, 36 (05) : 237 - 237
  • [10] Effect of ritanserin on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial
    Akhondzadeh, Shahin
    Malek-Hosseini, Mojgan
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (02) : 304 - 304
12345